Clostridioides difficile infection and testing rates in South Africa: A multicentre study, 2017-2020

Trusha Nana1, Praksha Ramjathan2, Khine Swe-Swe Han2

  • 1Department of Clinical Microbiology, Faculty of Health Sciences, University of Witwatersrand, 7 York Road, Parktown, Gauteng, 2193, South Africa; National Health Laboratory Service, Charlotte Maxeke Johannesburg Academic Hospital, Johannesburg, Gauteng, South Africa.

Anaerobe
|December 22, 2024
PubMed

Insights

Clostridioides difficile infection (CDI) rates varied significantly across three South African hospitals between 2017-2020. Testing practices also differed, with a notable CDI increase in 2020 during the SARS-CoV-2 outbreak.

Area of Science:

  • Infectious Diseases
  • Epidemiology
  • Public Health

Background:

  • Clostridioides difficile infection (CDI) is a significant healthcare-associated infection.
  • Surveillance of CDI rates and testing practices is crucial for effective management.
  • Understanding variations in CDI epidemiology is essential for targeted interventions.

Purpose of the Study:

  • To determine Clostridioides difficile infection (CDI) rates and testing practices.
  • To compare CDI epidemiology across three tertiary/quaternary hospitals in South Africa (SA).
  • To analyze trends from 2017 to 2020, including the impact of the SARS-CoV-2 outbreak.

Main Methods:

  • Retrospective review of laboratory records for C. difficile testing.
  • Analysis of clinical records to determine recurrent CDI (rCDI) rates.
  • Data collected from Charlotte Maxeke Johannesburg Academic Hospital (CMJAH), Tygerberg Hospital (TBH), and Inkosi Albert Luthuli Central Academic Hospital (IALCH).

Main Results:

  • Median primary CDI rates per 10,000 patient-days varied: 5.3 (CMJAH), 1.8 (TBH), and 0.3 (IALCH).
  • All hospitals observed an increase in primary CDI rates in 2020 compared to 2019.
  • Median testing rates per 10,000 patient-days also showed significant differences: 39 (CMJAH), 14 (TBH), and 4 (IALCH).
  • Recurrent CDI (rCDI) rates were low, ranging from 2 to 5 per 100 incident episodes.

Conclusions:

  • Significant disparities in CDI and testing rates exist among SA hospitals.
  • The 2020 SARS-CoV-2 outbreak correlated with increased CDI rates across all studied centers.
  • Systematic surveillance of healthcare-onset CDI in SA hospitals is recommended.
Abstract